International Market
Our business covers all parts of China, with 134 drug production approvals obtained and 104 products sold to 42 countries and regions worldwide.












Asia Pacific
Hong Kong
Macau
Taiwan
Japan
Mongolia
Thailand
Singapore
Philippines
Malaysia
Vietnam
Myanmar
East Timor
Indonesia
India
Pakistan
Bangladesh
Sri Lanka
Australia
Europe
Germany
Turkey
CIS Country & Middle Asia
Russia
Ukraine
Moldova
Uzbekistan
North America
United States
Mexico
Honduras
Latin America
Colombia
Brazil
Bolivia
Venezuela
Uruguay
Middle East & Africa
Yemen
Egypt
Guinea
Sierra Leone
Mali
Ghana
Democratic Republic of the Congo
Nigeria
Ethiopia
Kenya